IPCA Laboratories SWOT Analysis, USP & Competitors

IPCA Laboratories

Parent Company

Ipca Laboratories

Category

Pharmaceutical

Sector

Pharma and Healthcare

Tagline/ Slogan

A dose of life

USP

World leader in the anti malaria segment

IPCA Laboratories STP

Segment

Formulations, API, malaria, Nutraceutical, urology, nephrology therapeutic segment

Target Group

Health care professionals in the domestic and international market

Positioning

It is one of the largest pharmaceutical manufacturer & supplier

IPCA Laboratories SWOT Analysis

Strengths

1. Worldwide presence in the anti- malaria segment with almost a third of share in the market

2. Company has dosage forms against all malaria disorders

3. A large network of wholesalers, sales and marketing personnel and doctors spread across the country.

4. The sales increased by a considerable amount with the company’s center of attention on the formulation segment

5. Strong and stable financial position

Weaknesses

1. Intense competition means limited and slow market share growth

2. Focusing on promotional activities and brand building is less.

Opportunities

1. Increasing demand for therapeutic drugs in the Indian and Chinese market is hovering on the growth in coming decades

2. The acquisition of more and more research based firms will help increase the therapeutic product range to a great extent

3. Expansion in the therapeutic segment in Nutraceutical, nephrology and urology will improve profits

Threats

1. Reduced funds and infrastructure facilities for public healthcare is the cause of concern

2. Depreciating value of currency poses a threat to the research driven activities

3.Global economic slowdown

IPCA Laboratories Competition

Competitors

1. Plethico Pharma

2. Natco

3. Unichem

4. Merck